Cosela Injection, Powder, Lyophilized, For Solution
Product Images NDC 73462-101

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cosela (NDC 73462-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by G1 Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (G1x00 0001 01)

Chemical structure diagram of trilaciclib, the active ingredient in COSELA. The diagram shows the molecular framework including rings and functional groups consistent with the trilaciclib molecule.*

FDA Label Image

Principal Display Panel – 300 mg Vial Carton Label (G1x00 0001 02)

Label for COSELA (trilaciclib) injection, powder, lyophilized, for solution in 300 mg/vial strength. It is intended for intravenous infusion after reconstitution and dilution. The label includes storage instructions, distributor information (G1 Therapeutics, Inc.), preparation details, and barcodes. The package is for a single-dose vial with unused portions to be discarded.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.